Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Top tierCareDx is a precision medicine company dedicated to improving outcomes for transplant patients and advancing organ health. We deliver solutions designed to empower clinicians and improve patient outcomes. The Company's integrated solutions include non-invasive molecular testing for heart, kidney, and lung transplants; laboratory products; digital health technologies; and patient solutions that support care before and after transplant.
In the company’s own words · 10-K filed Feb 25, 2026 · SEC EDGAR
Business segments
Jun 2026 · $119.2MThe company’s own SEC segment disclosure.
- Service$99.9M84%
- Patient And Digital Solutions$19.2M16%
CareDx, Inc. (CDNA) reported revenue of $118M in Q1 2026 (quarter ended Mar 31, 2026), up 39% from the same quarter a year earlier. That came with net income of $2.8M (2.4% of revenue). For the full year FY2025, revenue was $380M (+14% year on year) and net income −$21M. Its largest product in Jun 2026 was Service at $100M, 84% of the disclosed total, well ahead of Patient And Digital Solutions at 16%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Diagnostics & Research
Ranks #3 of 17 by Smart Score